In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...
The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with ...
Dr. Vinitha Moopen of WellSpan Health Services stopped by the set of FOX43 Morning News to offer more on how to prevent RSV ...
Ahead of an advisory committee meeting later this week, the FDA revealed that all studies for RSV vaccines in young children ...
The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, accord ...
You may think you can avoid getting sick, but in Georgia, respiratory virus season is already upon us. Even if you lead an ...
RSV prevention among children, including nirsevimab and the maternal RSVpreF vaccine, may be associated with a reduction in pediatric ICU utilization.
While RSV is not on the CDC’s current list of Nationally Notifiable Diseases like COVID and influenza, a new rule from the ...
Research led by the CDC and conducted at seven academic pediatric medical centers in the United States finds nirsevimab (sold ...
Enanta Pharmaceuticals’ respiratory syncytial virus (RSV) antiviral reduced the viral load in a phase 2 study in children, ...
The figures for deaths weren't updated for that week. That last week of November was Thanksgiving week, when ...
Physicians in PA don’t expect to see the surges they saw during the first winters of the COVID-19 pandemic, but encouraged ...